{"log_id": 5433226047625523750, "direction": 0, "words_result_num": 25, "words_result": [{"probability": {"variance": 3e-06, "average": 0.998174, "min": 0.995378}, "location": {"width": 135, "top": 258, "height": 29, "left": 213}, "words": "【老年用药】"}, {"probability": {"variance": 0, "average": 0.989253, "min": 0.989073}, "location": {"width": 50, "top": 308, "height": 27, "left": 211}, "words": "本品"}, {"probability": {"variance": 0.001079, "average": 0.99291, "min": 0.802452}, "location": {"width": 833, "top": 339, "height": 46, "left": 209}, "words": "因为西格列汀和二甲双胍主要是通过肾脏排泄,而年龄的增长是与肾功能下降相"}, {"probability": {"variance": 4.6e-05, "average": 0.997192, "min": 0.967605}, "location": {"width": 831, "top": 387, "height": 44, "left": 210}, "words": "关的,因此随着患者年龄的增长应当谨慎服用本品。医生应仔细、规律地监测患"}, {"probability": {"variance": 1e-05, "average": 0.998404, "min": 0.982513}, "location": {"width": 806, "top": 435, "height": 44, "left": 211}, "words": "者的肾功能,并在此基础上谨慎选择药物剂量(参见注意事项一肾功能监测)"}, {"probability": {"variance": 6e-06, "average": 0.997913, "min": 0.99299}, "location": {"width": 146, "top": 539, "height": 27, "left": 217}, "words": "磷酸西格列汀"}, {"probability": {"variance": 0.000453, "average": 0.993756, "min": 0.872141}, "location": {"width": 832, "top": 572, "height": 43, "left": 212}, "words": "临床试验的结果表明,西格列汀在老年人群(≥65岁)中的安全性和疗效与年轻"}, {"probability": {"variance": 5.7e-05, "average": 0.994523, "min": 0.978868}, "location": {"width": 220, "top": 630, "height": 32, "left": 215}, "words": "患者(<65岁)相当"}, {"probability": {"variance": 0.019796, "average": 0.93146, "min": 0.61714}, "location": {"width": 146, "top": 719, "height": 32, "left": 219}, "words": "盐酸二甲双胍"}, {"probability": {"variance": 8e-06, "average": 0.998618, "min": 0.987315}, "location": {"width": 826, "top": 756, "height": 41, "left": 219}, "words": "二甲双胍的对照临床试验并没有招募到足够数量的老年患者,因此无法衡量老年"}, {"probability": {"variance": 0.000325, "average": 0.993009, "min": 0.905651}, "location": {"width": 813, "top": 803, "height": 43, "left": 218}, "words": "患者对药物的反应是否与年轻患者不同,尽管从其他已经取得的临床报道来看"}, {"probability": {"variance": 0.004525, "average": 0.978393, "min": 0.700503}, "location": {"width": 825, "top": 850, "height": 43, "left": 220}, "words": "还没有发现老年患者和年轻患者对药物反应的区别。已知甲双胍主要是通过背"}, {"probability": {"variance": 0.012045, "average": 0.974384, "min": 0.369926}, "location": {"width": 804, "top": 897, "height": 43, "left": 220}, "words": "脏排泄,由于肾功能受损的患者发生严重不良反应的风险更高,因此甲双"}, {"probability": {"variance": 5.4e-05, "average": 0.996653, "min": 0.968637}, "location": {"width": 404, "top": 950, "height": 38, "left": 220}, "words": "能用于肾功能正常的患者(参见禁忌)"}, {"probability": {"variance": 5e-06, "average": 0.997458, "min": 0.99247}, "location": {"width": 182, "top": 1045, "height": 29, "left": 232}, "words": "【药物相互作用】"}, {"probability": {"variance": 0.000686, "average": 0.98315, "min": 0.920493}, "location": {"width": 218, "top": 1091, "height": 33, "left": 228}, "words": "西格列汀和二甲双"}, {"probability": {"variance": 2.3e-05, "average": 0.996152, "min": 0.979749}, "location": {"width": 826, "top": 1127, "height": 43, "left": 228}, "words": "对于2型糖尿病患者,西格列汀(50mg,每日两次)和二甲双胍(1000mg,每日"}, {"probability": {"variance": 0.000202, "average": 0.994798, "min": 0.929911}, "location": {"width": 669, "top": 1176, "height": 41, "left": 226}, "words": "两次)多剂量联合给药并不会明显改变各成分药物的药代动力学"}, {"probability": {"variance": 0.000219, "average": 0.996694, "min": 0.910586}, "location": {"width": 829, "top": 1221, "height": 43, "left": 228}, "words": "尚无研究评价本品药代动力学方面的药物相互作用,但是,已有研究评价本品的"}, {"probability": {"variance": 1.7e-05, "average": 0.996474, "min": 0.987419}, "location": {"width": 311, "top": 1275, "height": 36, "left": 230}, "words": "独立成分西格列汀和二甲双胍"}, {"probability": {"variance": 2e-05, "average": 0.993929, "min": 0.987881}, "location": {"width": 146, "top": 1369, "height": 28, "left": 234}, "words": "磷酸西格列汀"}, {"probability": {"variance": 1.2e-05, "average": 0.998337, "min": 0.98008}, "location": {"width": 829, "top": 1402, "height": 45, "left": 232}, "words": "研究药物相互作用的试验表明,西格列汀对以下药物的药代动力学不会产生临床"}, {"probability": {"variance": 2.3e-05, "average": 0.997114, "min": 0.980012}, "location": {"width": 828, "top": 1449, "height": 45, "left": 233}, "words": "意义的影响:二甲双胍、罗格列酮、格列本脲、辛伐他汀、华法令以及口服避孕"}, {"probability": {"variance": 0.000401, "average": 0.990054, "min": 0.906501}, "location": {"width": 827, "top": 1498, "height": 42, "left": 233}, "words": "药。这些资料说明西格列汀不会抑制CYP辅酶CYP3A4、2C8或2C9。体内试验的"}, {"probability": {"variance": 0.000201, "average": 0.992127, "min": 0.939026}, "location": {"width": 829, "top": 1545, "height": 43, "left": 234}, "words": "结果也表明,西格列汀不会抑制CYP辅酶CYP2D6、1A2、2C19或2B6,也不会"}], "language": 3}